Ocular Therapeutix (OCUL) Other Accumulated Expenses (2013 - 2026)

Ocular Therapeutix's Other Accumulated Expenses history runs 14 years deep, the most recent figure standing at $1.7 million for Q1 2026.

• In Q1 2026, Other Accumulated Expenses rose 4.19% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (up 4.19% YoY), while the FY2025 annual figure was $1.9 million, down 6.76% from the prior year.
• Other Accumulated Expenses was $1.7 million for Q1 2026 at Ocular Therapeutix, down from $1.9 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $2.1 million in Q4 2024 to a low of $1.1 million in Q2 2022.
• Historically, Other Accumulated Expenses has averaged $1.6 million across 5 years, with a median of $1.6 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses soared 61.58% in 2024, then decreased 10.53% in 2025.
• A 5-year view of Other Accumulated Expenses shows it stood at $1.2 million in 2022, then grew by 24.19% to $1.5 million in 2023, then soared by 34.75% to $2.1 million in 2024, then decreased by 6.76% to $1.9 million in 2025, then decreased by 13.0% to $1.7 million in 2026.
• The last three Other Accumulated Expenses figures came in at $1.7 million (Q1 2026), $1.9 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.